Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2015 as an R&D, pre-revenue startup, TTC Oncology’s mission is to develop and bring to market a novel, small-molecule therapy to address unmet needs of breast cancer patients. TTC has a license from the University of Illinois at Chicago covering the therapy associated with modulation and mimicry of estrogen actions. Investigators completed Phase I trials on TTC drug at four sites and established drug safety. Inter...
Founded in 2015 as an R&D, pre-revenue startup, TTC Oncology’s mission is to develop and bring to market a novel, small-molecule therapy to address unmet needs of breast cancer patients. TTC has a license from the University of Illinois at Chicago covering the therapy associated with modulation and mimicry of estrogen actions. Investigators completed Phase I trials on TTC drug at four sites and established drug safety. International phase II clinical trials are in preparation.

List your booth number for exhibitions, ask us